RT @RICKLIN4TH: https://t.co/ZkesPvMvad why In the UK do we still recommend Axillary SLNB to women over 70 with Luminal A breast cancers wh…
https://t.co/ZkesPvMvad why In the UK do we still recommend Axillary SLNB to women over 70 with Luminal A breast cancers who have Cn0 axillary nodes. #save the axilla.
Despite these recommendations, rates of #SLNB actually increased with no additional benefit of #LRFS or #DFS. Read more of @neil_carleton_'s research on this topic: https://t.co/05gwUDDlk5 https://t.co/nCNPowhevL
This piggybacks off of some of our previous work, including: https://t.co/hnYwaa3h05 https://t.co/cUopZMklge
RT @neil_carleton_: This short paper was a follow up to our JAMA Netw Open analysis from last year: Outcomes of SLNB & RT in Older Women W…
This short paper was a follow up to our JAMA Netw Open analysis from last year: Outcomes of SLNB & RT in Older Women With Early-Stage Breast Cancer https://t.co/pkALcB1p3r via @JAMANetworkOpen part of @JAMANetwork
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
RT @neil_carleton_: Another nice article out in @AnnSurgOncol that confirms our recent paper in @JAMANetworkOpen - older women with HR+ bre…
Another nice article out in @AnnSurgOncol that confirms our recent paper in @JAMANetworkOpen - older women with HR+ breast cancer are being overtreated w/ SLNB & RT! https://t.co/Z7dBysJu6z https://t.co/n977zP6hGJ
RT @pash22: Deimplementation of both SLNB and RT interventions should be strongly considered in older patients with estrogen receptor–posit…
Deimplementation of both SLNB and RT interventions should be strongly considered in older patients with estrogen receptor–positive, clinically node-negative breast cancer. https://t.co/JqwHY04Q6O via @neil_carleton_ et al
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
This study found that receipt of SLNB or RT was not associated with improved LRFS or DFS in older patients with ER-positive, clinically node-negative breast cancer. https://t.co/AM6nPhjpXb
RT @leitaomd: We overtreat way too many women with various cancers and this demands smarter decisions and recommendations
RT @temkins: De-implementation of treatments that don't benefit patients remains a challenge. Sentinel nodes and radiation persist in the o…
Tratamiento menos agresivo a mujeres mayores de 70 años con #cancerdemama hormonodependiente en etapa temprana. #BreastcancerMéxico #mastólogo #Prosama https://t.co/FOCitWqt20
We overtreat way too many women with various cancers and this demands smarter decisions and recommendations
De-implementation of treatments that don't benefit patients remains a challenge. Sentinel nodes and radiation persist in the older patient with breast cancer despite a lack of benefit. https://t.co/0hZxiPZ5zw via @JAMANetworkOpen part of @JAMANetwork
RT @toddscarbrough: JAMA cohort study of 2109 older women (from UPMC)... “[They] don't necessarily need the sentinel lymph node biopsy sur…
JAMA cohort study of 2109 older women (from UPMC)... “[They] don't necessarily need the sentinel lymph node biopsy surgery and then radiation therapy.” https://t.co/tGYGmvXhEV "...deimplementation of SLNB and RT should be strongly considered..." https:
More evidence in favor of deimplementation of SLNB and RT in older women with HR+ breast cancer. Let’s keep working toward high quality of life and high value cancer care! 🧬 @leslydossett @alison_baskin @mary_shen @tashahughesmd https://t.co/mgDEytMrgW htt
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
RT @JAMANetworkOpen: Cohort study suggests that deimplementation of both SLNB and RT interventions should be strongly considered in older p…
RT @SWexner: Outcomes of Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage Breast Cancer https://t.co/Tq6rqmBysp via @JAMA…
Outcomes of Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage Breast Cancer https://t.co/Tq6rqmBysp via @JAMANetworkOpen part of @JAMANetwork
RT @PittCMU_MSTP: Check out this article by G1 @neil_carleton_ out now in @JAMANetworkOpen! Neil & co-authors outline a push for de-imple…
Outcomes of #Lymph #Node #Biopsy and #Radiotherapy in #Older #Women With Early-Stage #BreastCancer: https://t.co/jLXoa84bN4 via @JAMANetworkOpen part of @JAMANetwork
RT @CarlaFisherMD: As surgeons, we have to continue to look at these studies carefully and realize, we are doing too much and it’s not help…
As surgeons, we have to continue to look at these studies carefully and realize, we are doing too much and it’s not helping. #breastcancer
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer | Breast Cancer | JAMA Network Open | JAMA Network https://t.co/nQN64ZbBIb
RT @PittCMU_MSTP: Check out this article by G1 @neil_carleton_ out now in @JAMANetworkOpen! Neil & co-authors outline a push for de-imple…
Check out this article by G1 @neil_carleton_ out now in @JAMANetworkOpen! Neil & co-authors outline a push for de-implementation of SLNB & RT in elderly women with ER+ breast cancer! Link here: https://t.co/D33ZdCcwFa
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
New article: Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer https://t.co/6XibVeDkJi #breastcancer #oncology https://t.co/2fbALAqPqA
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
RT @JAMANetworkOpen: Cohort study suggests that deimplementation of both SLNB and RT interventions should be strongly considered in older p…
Cohort study suggests that deimplementation of both SLNB and RT interventions should be strongly considered in older patients with estrogen receptor–positive, clinically node-negative breast cancer. @adrianvlee @neil_carleton_ @oesterreichs @UPMCHillmanCC.
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
RT @Adrianvlee: Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https:…
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
RT @Adrianvlee: Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https:…
RT @neil_carleton_: 🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiothera…
🚨 Our new paper is out now in @JAMANetworkOpen @JAMANetwork: Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, ER+ Breast Cancer 🔗: https://t.co/ncTfo4OSFF @UPMCHillmanCC Press Release: https://t.co/rwSpDZhNa1
RT @Adrianvlee: Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https:…
RT @Adrianvlee: Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https:…
RT @Adrianvlee: Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https:…
RT @Adrianvlee: Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https:…
Our paper on lack of benefit of Lymph Node Biopsy and Radiotherapy in Older Women With ER+ Early-Stage Breast Cancer https://t.co/yxkpqsQ53t in @JAMANetworkOpen @oesterreichs @neil_carleton_ @UPMCHillmanCC @MageeWomens #BCSM